Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin

Blood

Volumn 101, Issue 8, 2003, Pages 3294-3301

  Liu, Enli ^b   Jelinek, Jaroslav ^b   Pastore, Yves D ^b   Guan, Yongli ^b   Prchal, Jaroslav F ^b   Prchal, Josef T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ERYTHROPOIETIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; AGAMMAGLOBULINAEMIA TYROSINE KINASE; ALLOANTIGEN; CD177 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; ASSAY; BURST FORMING UNIT E; CELL CULTURE; CHILD; CLINICAL OBSERVATION; CLONAL VARIATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA POLYMORPHISM; DRUG RESPONSE; ERYTHROID CELL; ETHNIC GROUP; FAMILIAL DISEASE; FEMALE; FHL1 GENE; GENE; GENETIC TRANSCRIPTION; GRANULOCYTE; HEMATOPOIESIS; HUMAN; MAJOR CLINICAL STUDY; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERTANT; THROMBOCYTOSIS; UNITED STATES; X CHROMOSOME; X CHROMOSOME INACTIVATION; BIOSYNTHESIS; BLOOD; CELL CLONE; CHEMISTRY; CLONOGENIC ASSAY; DRUG EFFECT; ERYTHROID PRECURSOR CELL; EXON; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYCYTHEMIA VERA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOMES, HUMAN, X; CLONE CELLS; COLONY-FORMING UNITS ASSAY; DIAGNOSIS, DIFFERENTIAL; DOSAGE COMPENSATION, GENETIC; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; EXONS; FEMALE; GENETIC MARKERS; GRANULOCYTES; HEMATOPOIESIS; HOMEODOMAIN PROTEINS; HUMANS; INTERFERON-ALPHA; ISOANTIGENS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYCYTHEMIA; POLYCYTHEMIA VERA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOCYTOSIS;

EID: 0038281343     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2287     Document Type: Article

References (55)

1. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976;295:913-916.
2. Prchal JT, Throckmorton DW, Carroll AJ III, Fuson EW, Gams RA, Prchal JF. A common progenitor for human myeloid and lymphoid cells. Nature. 1978;274:590-591.
3. Fialkow PJ, Gartler SM, Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci U S A. 1967;58:1468-1471.
4. Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood. 1981;58:916-919.
5. Kreipe H, Jaquet K, Feigner J, Radzun HJ, Parwaresch MR. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood. 1991;78:1814-1817.
6. Lyon MF. Gene action in the X chromosome of the mouse. Nature. 1961;190:372-373.
7. Beutler E, Yeh M, Fairbanks VF. The normal human female as a mosaic of X-chromosome activity: studies using the gene for G6PD deficiency as a marker. Proc Natl Acad Sci U S A. 1962;48:9-16.
8. Beutler E, Collins Z, Irwin LE. Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors. N Engl J Med. 1967;276:389-391.
9. Keith DH, Singer-Sam J, Riggs AD. Active X chromosome DNA is unmethylated at eight CCGG sites clustered in a guanine-plus-cytosine-rich island at the 5′ end of the gene for phosphoglycerate kinase. Mol Cell Biol. 1986;6:4122-4125.
10. Vogelstein B, Fearon ER, Hamilton SR, Feinberg AP. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science. 1985;227:642-645.
11. Vogelstein B, Fearon ER, Hamilton SR, et al. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res. 1987;47:4806-4813.
12. Boyd Y, Fraser NJ. Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status. Genomics. 1990;7:182-187.
13. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51:1229-1239.
14. Fey MF, Liechti-Gallati S, von Rohr A, et al. Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood. 1994;83:931-938.
15. Prchal JT, Guan YL. A novel clonality assay based on transcriptional analysis of the active X chromosome. Stem Cells. 1993;11(suppl 1):62-65.
16. Prchal JT, Guan YL, Prchal JF, Barany F. Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis. Blood. 1993;81:269-271.
17. Luhovy M, Liu Y, Belickova M, Prchal JF, Prchal JT. A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55. Biol Blood Marrow Transplant. 1995;1:81-87.
18. Liu Y, Phelan J, Go RC, Prchal JF, Prchal JT. Rapid determination of clonality by detection of two closely-linked X chromosome exonic polymorphisms using allele-specific PCR. J Clin Invest. 1997;99:1984-1990.
19. Gregg XT, Kralovics R, Prchal JT. A polymorphism of the X-linked gene IDS increases the number of females informative for transcriptional clonality assays. Am J Hematol. 2000;63:184-191.
20. Phelan JT II, Prchal JT. Clonality studies in cancer based on X chromosome inactivation phenomenon. Methods Mol Med. 2002;68:251-270.
21. El-Kassar N, Hetet G, Briere J, Grandchamp B. X-chromosome inactivation in healthy females: incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms. Clin Chem. 1998;44:61-67.
22. Curnutte JT, Hopkins PJ, Kuhl W, Beutler E. Studying X inactivation [letter]. Lancet. 1992;339:749.
23. El-Kassar N, Hetet G, Briere J, Grandchamp B. Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood. 1997;89:128-134.
24. Bunge S, Steglich C, Zuther C, et al. Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet. 1993;2:1871-1875.
25. Prchal JF, Axelrad AA. Bone-marrow responses in polycythemia vera [letter]. N Engl J Med. 1974;290:1382.
26. Eaves CJ, Eaves AC. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood. 1978;52:1196-1210.
27. Temednac S, Klippel S, Strunck E, et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood. 2000;95:2569-2576.
28. Klippel S, Strunck E, Temerinac S, et al. Quantification of PRV-1 expression, a molecular marker for the diagnosis of polycythemia vera [abstract]. Blood. 2001;98:470a.
29. Fruehauf S, Topaly J, Villalobos M, et al. Development of a new quantitative PCR-based assay for the polycythemia rubra vera-1 (PRV-1) gene: diagnostic and therapeutic implications [abstract]. Blood. 2001;98:629a.
30. Hoffman R. Polycythemia vera. In: Hoffman R, Benz EJJ, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. 3rd ed. New York, NY: Churchill Livingstone; 2000;1130-1151.
31. Scarpellini P, Braglia S, Brambilla AM, et al. Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system. J Clin Microbiol. 1997;35:2802-2806.
32. Kralovics R, Sokol L, Prchal JT. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. J Clin Invest. 1998;102:124-129.
33. Vorechovsky I, Vetrie D, Holland J, et al. Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-q22. Genomics. 1994;21:517-524.
34. Lee SM, Tsui SK, Chan KK, et al. Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1). Gene. 1998;216:163-170.
35. Gaetani GF, Ferraris AM, Galiano S, Giuntini P, Canepa L, d'Urso M. Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/Gd Mediterranean subject. Blood. 1982;59:76-79.
36. Tsukamoto N, Morita K, Maehara T, et al. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. Br J Haematol. 1994;86:253-258.
37. Smith CI, Baskin B, Humire-Greiff P, et al. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively downregulated in T lymphocytes and plasma cells. J Immunol. 1994;152:557-565.
38. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874-879.
39. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989;86:2766-2770.
40. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1991;1:34-38.
41. Conley ME, Fitch-Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet. 1994;3:1751-1756.
42. Fearon ER, Winkelstein JA, Civin CI, Pardoll DM, Vogelstein B. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl J Med. 1987;316:427-431.
43. Prchal JT. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders. Semin Hematol. 2001;38:10-20.
44. Prchal JT, Prchal JF, Belickova M, et al. Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism. J Exp Med. 1996;183:561-567.
45. Puck JM, Willard HF. X inactivation in females with X-linked disease. N Engl J Med. 1998;338:325-328.
46. Prchal JT, Carroll AJ, Prchal JF, et al. Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection. Blood. 1980;56:1048-1054.
47. Pastore YD, Jelinek J, Ang S, et al. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood. 2003;101:1591-1595.
48. Michiels JJ, Barbui T, Finazzi G, et al. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG. Leuk Lymphoma. 2000;36:239-253.
49. Harrison CN, Gale RE, Machin SJ, Linch DC. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood. 1999;93:417-424.
50. Axelrad AA, Eskinazi D, Correa PN, Amato D. Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia. Blood. 2000;96:3310-3321.
51. Shih LY, Lee CT. Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood. 1994;83:744-748.
52. Suzuki T, Higgins PJ, Crawford DR. Control selection for RNA quantitation. Biotechniques. 2000;29:332-337.
53. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun. 1999;259:523-526.
54. Ang SO, Chen H, Hirota K, et al. Congenital Chuvash polycythemia: altered oxygen homeostasis due to homozygosity for a hypomorphic VHL allele. Nat Genet. 2002;32:614-621.
55. Raaijmakers MH, van Emst L, de Witte T, Mensink E, Raymakers RA. Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain reaction. Exp Hematol. 2002;30:481-487.